Enabling Widespread Adoption of Transformative Biopharmaceutical Technologies: Insights from Roundtable 1 of the 2025 BioInnovation Group Executive Summit
By
Olga Paley, Carrie Mason
1mo agoen
Source
bioprocessintl.comEnabling Widespread Adoption of Transformative Biopharmaceutical Technologies: Insights from Roundtable 1 of the 2025 BioInnovation Group Executive Summitbioprocessintl.comSummarizing insights from the first of six roundtable discussions at the September 2025 BioInnovation Group (BIG) Executive Summit, this article explores why adoption of promising biotechnologies stalls and how to resolve that problem.
You might also wanna read
How AI Will Transform Biopharma: The Sequence of Change Matters
Ben Liu, CEO of Formation Bio, argues that AI will transform the pharmaceutical industry unevenly and sequentially. Some parts of drug disco
European biotech leaders explore China's role in global life sciences innovation at Paris roundtable
A roundtable discussion in Paris examined China's evolving role in the global biotechnology ecosystem, focusing on how European life science
Reuters Digital Health 2026: The End of the Single Decision-Maker in Healthcare Sales
The article reports key insights from the Reuters Digital Health 2026 event in Chicago, focusing on the shift away from traditional healthca
healthcareittoday.com·22d ago
Shaping the future of cardiometabolic innovation: advances and opportunities - Nature Metabolism
nature.com·11d ago

Computational Biologist Eleanor Howe Delivers Candid Assessment of Drug Discovery's Digital Transformation at Bio-IT World 2026
Eleanor Howe delivered the annual "Trends from the Trenches" address at Bio-IT World Conference & Expo 2026, offering a candid, buzzword-fre
bio-itworld.com·13d ago
China's biotech rise: A case study in multiple myeloma drug development
This article examines China's rapid advancement in biotechnology through the lens of a multiple myeloma drug development case study. It disc

Comments
Sign in to join the conversation.
No comments yet. Be the first.